As a result, we conclude that the level of serum clusterin in lung cancer have no significance correlation with malignance associate clinicopathological data (although the level of serum clusterin have significance difference between TNM stages, p = 0.0013, Table 3). The gene discussed is CLU; the disease is lung carcinoma.